MET and lung adenocarcinoma: The Cancer Genome Atlas (TCGA) showed that MET exon 14-skipping were present in about 4% (10/230) of lung adenocarcinoma, leading to partial or complete skipping deletion of MET exon14 at mRNA level (Cancer Genome Atlas Research Network, 2014).